Medicine
LMD in Dextrose 50 g/500 mL injection
LMD in Dextrose 50 g/500 mL injection is a prescription medicine containing Dextran 40 for intravenous use, marketed by Hospira, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20 to 25°C (68 to 77°F).
Key facts
- Active ingredient (INN)
- Dextran 40
- Brand
- LMD in Dextrose
- Strength
- 50 g/500 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 12 pouches of 500 mL
- Marketing authorisation holder
- Hospira
- Manufacturer
- Hospira
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20 to 25°C (68 to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 February 2006
- Identifiers
- RxCUI 244250DailyMed set ID 3c273512-84e2-2cea-b201-12345a6bd1feNDC 0409-7418Application BA720563
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 pouch in 1 case / 1 bag in 1 pouch / 500 mL in 1 bag | 0409-7418-03 | Hospira | 14 February 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dextran 40 50 g/500 mL injection.
Clinical summary
Dextran 40 is a plasma volume expander indicated in the adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma, among other approved uses. MedsAcross supplies Dextran 40 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Dextran 40For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LMD in Dextrose prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need LMD in Dextrose 50 g/500 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.